120 related articles for article (PubMed ID: 35081863)
1. Base of tongue squamous cell carcinomas, outcome depending on treatment strategy and p16 status. A population-based study from the Swedish Head and Neck Cancer Register.
Högmo A; Holmberg E; Haugen Cange H; Reizenstein J; Wennerberg J; Beran M; Söderkvist K; Hammerlid E; Sjödin H; Farnebo L; Sandström K; Hammarstedt-Nordenvall L; Zborayova K; Brun E
Acta Oncol; 2022 Apr; 61(4):433-440. PubMed ID: 35081863
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
5. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
[TBL] [Abstract][Full Text] [Related]
8. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the mobile tongue in young adults: A Swedish head & neck cancer register (SweHNCR) population-based analysis of prognosis in relation to age and stage.
Jonasson K; Sjövall J; Holmberg E; Beran M; Niklasson M; Kristiánsson S; Sandström K; Wennerberg J
Oral Oncol; 2023 Sep; 144():106485. PubMed ID: 37451141
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy in the treatment of Stage IV carcinoma of the base of tongue.
Cano ER; Johnson JT; Carrau R; Agarwala S; Flickinger J; Quader M
Brachytherapy; 2004; 3(1):41-8. PubMed ID: 15110313
[TBL] [Abstract][Full Text] [Related]
11. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
12. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
14. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
15. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
16. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
[TBL] [Abstract][Full Text] [Related]
17. A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients.
Rasmussen JH; Håkansson K; Rasmussen GB; Vogelius IR; Friborg J; Fischer BM; Bentzen SM; Specht L
Oral Oncol; 2018 Jun; 81():52-60. PubMed ID: 29884414
[TBL] [Abstract][Full Text] [Related]
18. A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.
Tertipis N; Hammar U; Näsman A; Vlastos A; Nordfors C; Grün N; Ährlund-Richter A; Sivars L; Haeggblom L; Marklund L; Hammarstedt-Nordenvall L; Chaturvedi AK; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
Eur J Cancer; 2015 Aug; 51(12):1580-7. PubMed ID: 26025766
[TBL] [Abstract][Full Text] [Related]
19. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies.
Takácsi-Nagy Z; Martínez-Mongue R; Mazeron JJ; Anker CJ; Harrison LB
Brachytherapy; 2017; 16(1):44-58. PubMed ID: 27592129
[TBL] [Abstract][Full Text] [Related]
20. National Cancer Database Analysis of the effect of brachytherapy on overall survival in patients with base of tongue cancer.
Silva SR; Martin B; Choi M; Emami B; Hurst NJ
Head Neck; 2019 May; 41(5):1184-1192. PubMed ID: 30788877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]